PELP1/SRC-3-dependent regulation of metabolic PFKFB kinases drives therapy resistant ER+ breast cancer

Recurrence of metastatic breast cancer stemming from acquired endocrine and chemotherapy resistance remains a health burden for women with luminal (ER+) breast cancer. Disseminated ER+ tumor cells can remain viable but quiescent for years to decades. Contributing factors to metastatic spread include...

Descripción completa

Detalles Bibliográficos
Autores principales: Truong, Thu H., Benner, Elizabeth A., Hagen, Kyla M., Temiz, Nuri A., Kerkvliet, Carlos Perez, Wang, Ying, Cortes-Sanchez, Emilio, Yang, Chieh-Hsiang, Trousdell, Marygrace C., Pengo, Thomas, Guillen, Katrin P., Welm, Bryan E., Dos Santos, Camila O., Telang, Sucheta, Lange, Carol A., Ostrander, Julie H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238912/
https://www.ncbi.nlm.nih.gov/pubmed/34103681
http://dx.doi.org/10.1038/s41388-021-01871-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8238912/
https://www.ncbi.nlm.nih.gov/pubmed/34103681
http://dx.doi.org/10.1038/s41388-021-01871-w

Ejemplares similares